Induced pluripotent stem cells are cells derived from the skin or blood that have been reprogrammed back to an embryonic-like pluripotent state. This enables these cells to differentiate into various cell types and can be expanded indefinitely for therapeutic purposes.
The ground breaking work in this technology was discovered by the Japanese scientist Shinya Yamanaka and his team in 2006. They successfully reprogrammed somatic cells into induced pluripotent stem cells by transducing a specific set of genes such as Oct4, Sox2, c-Myc, and Klf4.